Lipid nanoparticle-encapsulated mRNA therapy corrects serum total bilirubin level in Crigler-Najjar syndrome mouse model

Crigler-Najjar syndrome is a rare disorder of bilirubin metabolism caused by uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1) mutations characterized by hyperbilirubinemia and jaundice. No cure currently exists; treatment options are limited to phototherapy, whose effectiveness diminishes o...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jenny A. Greig, Joanna K. Chorazeczewski, Vivek Chowdhary, Melanie K. Smith, Matthew Jennis, James C. Tarrant, Elizabeth L. Buza, Kimberly Coughlan, Paolo G.V. Martini, James M. Wilson
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-06-01
coleção:	Molecular Therapy: Methods & Clinical Development
Assuntos:	Crigler-Najjar lipid nanoparticle LNP mRNA UGT1A1 hyperbilirubinemia
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2329050123000177
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!